JACK SU to Risk Assessment
This is a "connection" page, showing publications JACK SU has written about Risk Assessment.
Connection Strength
0.024
-
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). J Clin Oncol. 2021 03 01; 39(7):822-835.
Score: 0.024